Naproxen Sodium

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

30 Suppliers, 22 USDMF, 6 CEP/COS, 5 EU WC, 34 KDMF, 12 NDC API, 9 Listed Suppliers

DEVELOPMENTS

6 Drug(s) in Development

6 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

147 Dossiers, 85 FDA Orange Book, 13 Europe, 19 Canada, 4 South Africa, 26 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 500MG BASE, TABLET;ORAL - 220MG, TABLET, EXTENDED RELEASE;ORAL - EQ 375MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 500MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 750MG BASE, CAPSULE;ORAL - EQ 200MG BASE, TABLET;ORAL - 500MG;EQ 85MG BASE, TABLET;ORAL - 60MG;EQ 10MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 38 Roquette, 33 Kerry, 33 BASF, 20 Microlex e.U, 19 SPI Pharma, 17 Corel Pharma Chem, 14 Gangwal Healthcare, 13 Seppic, 13 Gangwal Chemicals, 12 Nanjing Well Pharmaceutical, 12 Sigachi Industries, 11 Actylis, 11 Boai NKY Pharmaceuticals Ltd, 11 Ideal Cures Pvt Ltd, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 DKSH, 9 Pluviaendo, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Lonza Capsugel, 6 DFE Pharma, 5 Ingredion Pharma Solutions, 4 Kima Chemical, 4 Vasa Pharmachem, 4 Pharmatrans-Sanaq, 4 ACG Worldwide, 4 Novo Excipients, 4 Prachin Chemical, 4 Rochem International Inc, 4 Ulanqab Kema New Material, 3 Clariant, 3 Evonik, 3 The Dow Chemical Company, 2 Jai Radhe Sales, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Aeon Procare, 2 Qualicaps, 2 Pfanstiehl, 2 Seqens, 2 Nomisma Healthcare, 2 Finar, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Valens Pharmachem, 1 Alcedo Pharmachem, 1 Nanjing Bold Chemical, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

105 Fillers, Diluents & Binders, 65 Coating Systems & Additives, 49 Direct Compression, 44 Controlled & Modified Release, 43 Disintegrants & Superdisintegrants, 42 Thickeners and Stabilizers, 37 Solubilizers, 32 Parenteral, 31 Granulation, 29 Film Formers & Plasticizers, 25 Taste Masking, 24 Topical, 24 Lubricants & Glidants, 21 Co-Processed Excipients, 19 Chewable & Orodispersible Aids, 9 Emulsifying Agents, 9 Rheology Modifiers, 9 Empty Capsules, 9 API Stability Enhancers, 5 Coloring Agents, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 10 Finished Drug Prices

MARKET PLACE

37 APIs, 2 DOSSIERS // FDF

PATENTS

12 US Patents, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 BioAnalytical Methods, 3 EDQM, 1 USP, 1 Others

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 44 News

Pharmacy pricing data of Naproxen Sodium obtained from U.S. Medicaid's National Average Drug Acquisition Cost

Naproxen Sodium

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

30 Suppliers

22 USDMF

6 CEP/COS

5 EU WC

34 KDMF

12 NDC API

9 Listed Suppliers

DEVELOPMENTS

6 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

147 Dossiers

85 FDA Orange Book

13 Europe

19 Canada

4 South Africa

26 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 500MG BASE

TABLET;ORAL - 220MG

TABLET, EXTENDED RELEASE;ORAL - EQ 375MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 500MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 750MG BASE

CAPSULE;ORAL - EQ 200MG BASE

TABLET;ORAL - 500MG;EQ 85MG BASE

TABLET;ORAL - 60MG;EQ 10MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

38 Roquette

33 Kerry

33 BASF

20 Microlex e.U

19 SPI Pharma

17 Corel Pharma Chem

14 Gangwal Healthcare

13 Seppic

13 Gangwal Chemicals

12 Nanjing Well Pharmaceutical

12 Sigachi Industries

11 Actylis

11 Boai NKY Pharmaceuticals Ltd

11 Ideal Cures Pvt Ltd

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 DKSH

9 Pluviaendo

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Lonza Capsugel

6 DFE Pharma

5 Ingredion Pharma Solutions

4 Kima Chemical

4 Vasa Pharmachem

4 Pharmatrans-Sanaq

4 ACG Worldwide

4 Novo Excipients

4 Prachin Chemical

4 Rochem International Inc

4 Ulanqab Kema New Material

3 Clariant

3 Evonik

3 The Dow Chemical Company

2 Jai Radhe Sales

2 Shijiazhuang Huaxu Pharmaceutical

2 Aeon Procare

2 Qualicaps

2 Pfanstiehl

2 Seqens

2 Nomisma Healthcare

2 Finar

1 Qianhao Chemical (Hebei) Co., Ltd

TABLET;ORAL - EQ 250MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons